Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by skyhigh123on Mar 12, 2018 12:11pm

133 Views

Post# 27700956

RE:RE:RE:RE:Next step management will have to raise more

I’am very heavily invested in another biotech stock and there FDA BLA approval date is April 14 and yours was April 6 . Almost 1 month ahead of schedule so iam anticipating and early Approval for our Orphan Drug and a Pediatric Review Voucher which the company can sell . Only 17-18 Vouchers have been given out in roughly 25 years they have sold for $350 Million - $60 Million US dollars .
I’ll be back when your reach $13 good luck to everyone.
sky
(PLI)

Bullboard Posts

Unlocking potential in TAG Oil’s Badr Oilfield Abu-Roash 'F' project